Wellcome’s first access to healthcare interventions report outlines major challenges faced by funders of R&D for health, and makes five commitments.
[Summary] Wellcome’s first access to healthcare interventions report outlines major challenges faced by funders of R&D for health, and makes five commitments.
Effective regulatory oversight is needed to make sure emerging science and technologies reach their full potential quickly and safely, and with the public's trust. Our report sets out how the UK can become a world leader in this area.
[Summary] Effective regulatory oversight is needed to make sure emerging science and technologies reach their full potential quickly and safely, and with the public's trust. Our report sets out how the UK can become a world leader in this area.
Our workshop with the Gates Foundation and the Academy of Medical Sciences looked at how the current guidelines for clinical trials could be improved, and possible alternative approaches.
Four realistic and achievable options for regulatory cooperation in UK-EU clinical trials, including costs and opportunities.
[Summary] Four realistic and achievable options for regulatory cooperation in UK-EU clinical trials, including costs and opportunities.
How funders can work with the research community to improve data access, governance and management.
Our recommendations on EU-UK science and innovation post-Brexit.
Case studies on EU funding, including the areas of epigenomics, dementia, reputation and innovation.
Through a series of case studies, we demonstrate how strategic institutional support has helped research thrive in universities across the UK.
We look at how science should be included in the framework for a future EU-UK relationship.
We discuss ways to improve collaboration between the European Commission and private foundations.
With 11 other organisations, we sign a joint statement on ways to improve collaboration between the European Commission and private foundations.
[Summary] Wellcome’s recommendations on what should be included in a new EU-UK research partnership and how it could be delivered. It is based on the views of European and UK experts.
A briefing on the economic benefits of musculoskeletal disease research in the UK.
Together with the Royal Society, we asked individuals and organisations from across the UK and EU for their recommendations about how future research and innovation partnerships should work after Brexit.
A synthesis of the existing evidence on the EU-UK relationship on research and innovation, produced by the Royal Society.
[Summary] Facts and figures on UK primary science education across the UK – from how science is taught, to what pupils think of it.
Eight commitments from the Academy of Medical Science, Royal Academy of Engineering, Royal Society and Wellcome to create a culture that allows research and translation to thrive.